A novel micronucleus in vitro assay utilizing human hematopoietic stem cells

Area of Science:

• Toxicology
• Cell Biology
• Hematology

Background:

• Micronucleus assays in rodents are standard for genotoxicity testing, detecting chromosomal damage.
• Animal testing raises ethical concerns and limitations in predicting human responses.
• The 3Rs principle (replace, reduce, refine) drives the development of alternative methods.

Purpose of the Study:

• To develop and validate an in vitro micronucleus assay using cultured human red blood cells.
• To establish an animal-free, human cell-based system for genotoxicity assessment.
• To create a sensitive, cost-effective assay suitable for high-throughput screening.

Main Methods:

• Development of an ex vivo culture system for human red blood cells derived from hematopoietic stem cells.
• Testing of diverse chemical agents including clastogens (direct and metabolically activated), aneugens, and non-genotoxic compounds.
• Application of various metabolic systems to simulate in vivo activation.
• Detection and enumeration of micronuclei using flow cytometry.

Main Results:

• The developed in vitro assay demonstrated sensitivity in detecting genotoxicity.
• Results obtained were consistent with established data from in vivo and other in vitro studies.
• The assay proved effective across different classes of genotoxic and non-genotoxic compounds.
• Flow cytometry provided efficient detection and quantification of micronuclei.

Conclusions:

• A validated, sensitive, and cost-effective in vitro micronucleus assay using human red blood cells has been developed.
• This human cell-based assay offers a promising alternative to animal testing for genotoxicity.
• The assay has potential for high-throughput screening, advancing patient safety and the 3Rs principles.